Newtown Square, PACIK 21069391 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
85 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Ishares Tr | 700.0K | $70.27M | 61.4% | +700.0K | New Position |
| 2 | Praxis Precision Medicines I | 2.0K | $584.2K | 0.5% | +2.0K | New Position |
| 3 | Travere Therapeutics Inc | 15.3K | $583.5K | 0.5% | +15.3K | New Position |
| 4 |
| Tyra Biosciences Inc |
| 21.9K |
| $574.5K |
| 0.5% |
| +21.9K |
| New Position |
| 5 | Pharvaris N V | 20.5K | $569.2K | 0.5% | +20.5K | New Position |
| 6 | Jazz Pharmaceuticals PLC | 3.3K | $553.9K | 0.5% | +3.3K | New Position |
| 7 | Celldex Therapeutics Inc New | 20.4K | $553.2K | 0.5% | +20.4K | New Position |
| 8 | Cg Oncology Inc | 13.3K | $551.9K | 0.5% | +13.3K | New Position |
| 9 | Belite Bio Inc | 3.4K | $550.7K | 0.5% | +3.4K | New Position |
| 10 | Ascendis Pharma A/S | 2.6K | $549.9K | 0.5% | +2.6K | New Position |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio